Core Wealth Advisors (Florida)’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-201
Closed -$33K 215
2021
Q3
$33K Sell
201
-10
-5% -$1.71K 0.02% 93
2021
Q2
$36K Sell
211
-43
-17% -$7.1K 0.02% 81
2021
Q1
$41K Sell
254
-89
-26% -$15.2K 0.04% 68
2020
Q4
$58K Sell
343
-66
-16% -$10.7K 0.05% 49
2020
Q3
$64K Hold
409
0.06% 45
2020
Q2
$69K Buy
+409
New +$64.2K 0.06% 51

Other funds holding FBT

Core Wealth Advisors (Florida)'s FBT Position: Q4 2021 in Review

Core Wealth Advisors (Florida) sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2021, closing a stake of 201 shares — an estimated $33K sold.

Core Wealth Advisors (Florida) first reported a position in FBT in Q2 2020 and held it in 6 quarters. The position peaked at $69K in Q2 2020. 247 funds tracked by Wall St. Rank hold FBT as of Q4 2021.

  • Core Wealth Advisors (Florida) reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2021 after selling out during the quarter.
  • Core Wealth Advisors (Florida) sold 201 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2021, an estimated $33K.
  • Core Wealth Advisors (Florida) first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and held it in 6 quarters.
  • Core Wealth Advisors (Florida)'s First Trust NYSE Arca Biotechnology Index Fund position peaked at $69K in Q2 2020.
  • 247 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2021.

Based on Core Wealth Advisors (Florida)'s 13F filing for Q4 2021, filed 14 Feb 2022.